Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 2/20 | 0.73 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.73 |
| ▸ | TSHR | P16473 | 1/20 | 0.73 |
| ▸ | F2 | P00734 | 1/20 | 0.73 |
| ▸ | DPP4 | P27487 | 1/20 | 0.73 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.69 |
| ▸ | CTSD | P07339 | 1/20 | 0.66 |
| ▸ | MEN1 | O00255 | 1/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.61 |
| ▸ | POLA1 | P09884 | 1/20 | 0.60 |
| ▸ | NPC1 | O15118 | 1/20 | 0.60 |
| ▸ | CYP46A1 | Q9Y6A2 | 1/20 | 0.59 |
| ▸ | NR1H3 | Q13133 | 4/20 | 0.58 |
| ▸ | GRIN1 | Q05586 | 3/20 | 0.58 |
| ▸ | GRIN2A | Q12879 | 3/20 | 0.58 |
| ▸ | GRIN2B | Q13224 | 3/20 | 0.58 |
| ▸ | EPHA2 | P29317 | 3/20 | 0.58 |
| ▸ | OSBP | P22059 | 2/20 | 0.58 |
| ▸ | RORC | P51449 | 1/20 | 0.58 |
| ▸ | OSBP2 | Q969R2 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Sitosteryl Acetate SCHEMBL25679307 | 1.00 | POLB (0.73) | POLBTDP1TSHRF2DPP4 | |
| SCHEMBL19581467 | 0.92 | POLB (0.72) | POLBTDP1TSHRF2DPP4 | |
| SCHEMBL32671059 | 0.92 | POLB (0.72) | POLBTDP1TSHRF2DPP4 | |
| SCHEMBL4736527 | 0.92 | POLB (0.72) | POLBTDP1TSHRF2DPP4 | |
| SCHEMBL19581466 | 0.92 | POLB (0.72) | POLBTDP1TSHRF2DPP4 | |
| SCHEMBL24015445 | 0.92 | POLB (0.72) | POLBTDP1TSHRF2DPP4 | |
| SCHEMBL24015354 | 0.92 | POLB (0.71) | POLBTDP1TSHRF2DPP4 | |
| SCHEMBL25352872 | 0.91 | POLB (0.70) | POLBTDP1TSHRF2DPP4 | |
| SCHEMBL25358326 | 0.91 | POLB (0.70) | POLBTDP1TSHRF2DPP4 | |
| SCHEMBL25358335 | 0.91 | POLB (0.70) | POLBTDP1TSHRF2DPP4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 506 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119997933-A | Oral pharmaceutical composition containing taxane and preparation method thereof | 韩国科学技术研究院 | 2025-05-13 | — | — | CN | claimed |
| CN-118717785-B | Pharmaceutical composition for preventing and treating scar hyperplasia and preparation method and application thereof | 威海人生药业有限公司 | 2025-03-28 | — | — | CN | claimed |
| CN-118717785-A | Pharmaceutical composition for preventing and treating scar hyperplasia and preparation method and application thereof | 威海人生药业有限公司 | 2024-10-01 | — | — | CN | claimed |
| CN-118593390-A | Tricholoma matsutake extract with whitening effect and preparation method thereof | 云南英格生物技术有限公司 | 2024-09-06 | — | — | CN | claimed |
| WO-2024076056-A1 | ORAL PHARMACEUTICAL COMPOSITION CONTAINING TAXANE AND PREPARATION METHOD THEREFOR | 한국과학기술연구원 | 2024-04-11 | — | — | WO | claimed |
| CN-117502321-A | Method for screening apocynum venetum oxytocin and application of oxytocin | 滨州市海洋发展研究院 | 2024-02-06 | — | — | CN | claimed |
| CN-114354774-A | Detection method of fingerprint of corn oil unsaponifiable matter and standard fingerprint thereof | 湖南天龙制药有限公司 | 2022-04-15 | — | — | CN | claimed |
| CN-114306547-A | Traditional Chinese medicine formula for regulating and controlling intestinal function of pregnant women | 华子昂 | 2022-04-12 | — | — | CN | claimed |
| CN-112999158-B | Preparation method and application of policosanol nano-liposome | 江西省科学院生物资源研究所 | 2022-04-01 | — | — | CN | claimed |
| CN-112999158-A | Preparation method and application of policosanol nano-liposome | 江西省科学院生物资源研究所 | 2021-06-22 | — | — | CN | claimed |
| US-20260091072-A1 | FOOD PRODUCTS COMPRISING OXALIC ACID- OR OXALATE-FREE INONOTUS OBLIQUUS EXTRACT | THE BETTER FOR YOU COMPANY, LLC (US) | 2026-04-02 | — | — | US | disclosed |
| EP-4704600-A1 | DAIRY BEVERAGES WITH IMPROVED TASTE | The Coca-Cola Company (US) | 2026-03-11 | — | — | EP | disclosed |
| EP-4704601-A1 | DAIRY-ALTERNATIVE BEVERAGES WITH IMPROVED TASTE | The Coca-Cola Company (US) | 2026-03-11 | — | — | EP | disclosed |
| US-20260055130-A1 | METHODS FOR PURIFYING STEVIOL GLYCOSIDES AND USES OF THE SAME | PURECIRCLE SDN BHD (MY) | 2026-02-26 | — | — | US | disclosed |
| US-12557831-B2 | Mogrosides and uses of the same | THE COCA-COLA COMPANY (US) | 2026-02-24 | — | — | US | disclosed |
| US-5958913-A | ADMINISTERING SATURATED STEROL FATTY ACID ESTER | RAISIO BENECOL LTD. (FI) | 1999-09-28 | — | — | US | disclosed |
| EP-0594612-B1 | A SUBSTANCE FOR LOWERING HIGH CHOLESTEROL LEVEL IN SERUM AND A METHOD FOR PREPARING THE SAME | RAISION TEHTAAT OY AB (FI) | 1997-08-06 | — | — | EP | disclosed |
| US-5502045-A | REDUCING ABSORPTION OF CHOLESTEROL IN BLOOD USING SITOSTANOL FATTY ESTER | RAISION TEHTAAT OY AB (FI) | 1996-03-26 | — | — | US | disclosed |
| EP-0594612-A1 | A SUBSTANCE FOR LOWERING HIGH CHOLESTEROL LEVEL IN SERUM AND A METHOD FOR PREPARING THE SAME. | RAISION MARGARIINI OY (FI) | 1994-05-04 | — | — | EP | disclosed |
| WO-1992019640-A1 | A SUBSTANCE FOR LOWERING HIGH CHOLESTEROL LEVEL IN SERUM AND A METHOD FOR PREPARING THE SAME | RAISION MARGARIINI OY (FI) | 1992-11-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12557831-B2 | Mogrosides and uses of the same | TAS2R40, TAS2R20, TAS2R10 | POLB 4673/4885TDP1 4687/4885TSHR 2379/4885 |
| US-20260055130-A1 | METHODS FOR PURIFYING STEVIOL GLYCOSIDES AND USES OF THE SAME | TAS2R7, TAS2R42, TAS2R31 | POLB 3894/4885TDP1 1920/4885TSHR 1727/4885 |
| US-20260091072-A1 | FOOD PRODUCTS COMPRISING OXALIC ACID- OR OXALATE-FREE INONOTUS OBLIQUUS EXTRACT | ORAI1, OTC, ORAI2 | POLB 2983/4885TDP1 1765/4885TSHR 1021/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.